InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (16 ops.)
Discover the complete record of transactions filed by Ackermann Michael, Director. Insider active across 1 companies, notably Tarsus Pharmaceuticals, Inc.. Cumulatively, 20 filings have been logged. Total volume traded: €2.1m. The latest transaction was filed on 5 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations20 total
4,257 shares
Common Stock
SEC:0001209191-22-037924:0·
€1m100,000 shares@ €12.80870.048% mcap59.9% of flow
Common Stock
SEC:0001209191-22-027856:0·
Ideal exit: 30 Jan 2023 (T+270)
€51,4042,442 shares@ €21.04980.0019% mcap12.0% of flow
Common Stock
SEC:0001819790-21-000059·
€51,4042,442 shares@ €21.04980.0019% mcap2.4% of flow
Common Stock
SEC:0001819790-21-000059:0·
€119,2394,964 shares@ €24.02070.0044% mcap27.8% of flow
Common Stock
SEC:0001819790-21-000043·
€119,2394,964 shares@ €24.02070.0044% mcap5.6% of flow
Common Stock
SEC:0001819790-21-000043:0·
€24,7311,116 shares@ €22.16050.0009% mcap5.8% of flow
Common Stock
SEC:0001819790-21-000039·
€24,7311,116 shares@ €22.16050.0009% mcap1.2% of flow
Common Stock
SEC:0001819790-21-000039:0·
€4,331200 shares@ €21.65270.0002% mcap1.0% of flow
Common Stock
SEC:0001819790-21-000035·
€4,331200 shares@ €21.65270.0002% mcap0.2% of flow
Common Stock
SEC:0001819790-21-000035:0·
€124,3465,833 shares@ €21.31760.0046% mcap29.0% of flow
Common Stock
SEC:0001209191-21-054888·
€124,3465,833 shares@ €21.31760.0046% mcap5.8% of flow
Common Stock
SEC:0001209191-21-054888:0·
€13,302621 shares@ €21.42070.0005% mcap3.1% of flow
Common Stock
SEC:0001209191-21-051193·
€13,302621 shares@ €21.42070.0005% mcap0.6% of flow
Common Stock
SEC:0001209191-21-051193:0·
€66,0923,129 shares@ €21.12250.0025% mcap15.4% of flow
Common Stock
SEC:0001209191-21-050631·
€66,0923,129 shares@ €21.12250.0025% mcap3.1% of flow
Common Stock
SEC:0001209191-21-050631:0·
€24,9881,183 shares@ €21.12250.0009% mcap5.8% of flow
Common Stock
SEC:0001209191-21-050177·
€24,9881,183 shares@ €21.12250.0009% mcap1.2% of flow
Common Stock
SEC:0001209191-21-050177:0·
04,257 shares0
Common Stock
SEC:0001209191-21-041701·
04,257 shares0
Common Stock
SEC:0001209191-21-041701:0·
20 of 20 declarations
About Ackermann Michael
Michael Ackermann is an executive at Tarsus Pharmaceuticals, Inc.
